chr22-39101977-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_181773.5(APOBEC3H):āc.478T>Gā(p.Tyr160Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000116 in 1,613,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_181773.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
APOBEC3H | NM_181773.5 | c.478T>G | p.Tyr160Asp | missense_variant | 4/5 | ENST00000442487.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
APOBEC3H | ENST00000442487.8 | c.478T>G | p.Tyr160Asp | missense_variant | 4/5 | 3 | NM_181773.5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 151728Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251390Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135876
GnomAD4 exome AF: 0.000114 AC: 167AN: 1461770Hom.: 0 Cov.: 31 AF XY: 0.000103 AC XY: 75AN XY: 727196
GnomAD4 genome AF: 0.000132 AC: 20AN: 151728Hom.: 0 Cov.: 30 AF XY: 0.000108 AC XY: 8AN XY: 74078
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2023 | The c.478T>G (p.Y160D) alteration is located in exon 4 (coding exon 3) of the APOBEC3H gene. This alteration results from a T to G substitution at nucleotide position 478, causing the tyrosine (Y) at amino acid position 160 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at